70 – Identifying Protective Behaviors in Athletes to Promote Anti-Doping Adherence – Lindsay Duncan, PhD
Dr. Lindsay Duncan is a professor in the Kinesiology and Physical Education Department at McGill University in Montreal. She specializes in health psychology, health communication, and health interventions. She joins us in this interview to talk about new research focused on guiding athlete behavior in the anti-doping space, specifically investigating athlete protective behaviors.
Support This Podcast
Interested in sponsoring the Anti-Doping Podcast or have a guest recommendation?
69 – A Look Inside iNADO and Review of Anti-Doping Research – Jorge Leyva
Jorge Leyva serves as the CEO of the Institute of National Anti-Doping Organisations, also known as iNADO. The organization provides advocacy and support for national anti-doping agencies all over the world. Jorge joins us today to discuss iNADO operations as well as a recent review that the organization conducted regarding the last few decades of anti-doping research.
68 – The Critical Role of Whistleblowers in the Fight Against Doping – Günter Younger
Günter Younger works as the Director of Intelligence and Investigations for the World Anti-Doping Agency (WADA). He comes to the position from a background in law enforcement. In this episode, Günter joins us to talk about the role of whistleblowers in anti-doping, steps being taken to protect whistleblowers, and confidential resources available for people to report suspected wrong-doing in sport.
67 – USADA’s Commitment to Athlete and International Relations in Anti-Doping – Allison Wagner
Allison Wagner serves as the US Anti-Doping Agency’s first Director of Athlete and International Relations. She was formerly an All-American, Olympic, and World Champion swimmer, and her accomplishments include a silver medal in the Atlanta Olympic Games and a former world record set in the World Championships in Palma de Mallorca. Now, Allison is using her experience as an athlete to serve as a voice for others. She joins us in this episode to discuss her role in anti-doping.
66 – Advancing Our Ability to Detect Blood Doping – Nicolas Leuenberger, PhD
Dr. Nicolas Leuenberger conducts research for the Swiss Anti-Doping Lab and the University of Lausanne. His research has traditionally focused on blood doping, and he has also done extensive work on identifying biomarkers in dried blood spots. Nicolas joins us in this episode to discuss his haematological research and his thoughts on the future of detection methods for blood doping.
65 – An Inside Look at the World Anti-Doping Agency’s Athlete Committee – Ben Sandford
Ben Sandford is a three time Olympian competing in skeleton racing for New Zealand, and he received the Bronze Medal at the 2012 Bobsleigh and Skeleton World Championships. Since wrapping up his athletic career in 2014, he has become the chair of the World Anti-Doping Agency (WADA)’s Athlete Committee. He is also a Member of the New Zealand Olympic Committee Athlete Commission and an attorney with Sandford & Partners. Ben joins us to discuss his experiences and WADA’s efforts to integrate the athlete voice.
64 – Developing Novel Anti-Doping Assays to Monitor Collagen Turnover – Andy Hoofnagle, MD, PhD
Dr. Andy Hoofnagle is a researcher, professor, board certified pathologist, and laboratory director at the University of Washington. Dr. Hoofnagle’s laboratory focuses on research and development of novel biomarker assays that use mass spectrometry. Andy joins us in this episode to discuss his work in anti-doping, specifically with a focus on the development of assays to measure markers of collagen turnover for anti-doping applications.
63 – How to Secure Anti-Doping Research Funding – Annette Salmeen, PhD
Dr. Annette Salmeen was a 1996 Olympian and gold medalist in swimming. In 2005, she was elected as an athlete member of the USADA Board of Directors, and she served on the board until 2012. Currently, Annette is a lecturer and Core Course Coordinator in the Human Biology Program at Stanford University, and she’s also a member of the Partnership for Clean Competition’s Scientific Advisory Board. In this episode she discusses best practices for applying for anti-doping research grants from the PCC.
62 – The Anti-Doping Agency of Kenya’s Commitment to Clean Sport – Sarah Shibutse
Sarah Shibutse is the Director of Standards and Compliance at the Anti-Doping Agency of Kenya (ADAK). She served as a joint secretary to the Anti-Doping Task Force that was set up by the Ministry of Sports to investigate the extent of doping in Kenya. In this episode, we discuss the findings of this Task Force and the history of ADAK. Sarah shares what it was like creating a national anti-doping organization from the ground up, current challenges they are facing, their goals for the future, and more.
61 – Delivering Innovative Solutions to Fight Doping and Other Sport Integrity Issues – Dominic Mueser
Dominic Mueser has worked in anti-doping for more than a decade, much of it with Germany’s national anti-doping agency. Today, he works at Sportradar, where he serves as the Global Head of Anti-Doping Services. Sportradar primarily collects and analyzes sports data, providing information to everyone from international sports federations to bookmakers. Dominic joins us in this episode to discuss Sportradar’s role in the anti-doping space and how data can be used to help ensure clean sport.
60 – Leading Rigorous Anti-Doping Efforts in Canada – Jeremy Luke
Jeremy Luke is Senior Director of Sport Integrity at the Canadian Center for Ethics in Sport (CCES), the Canadian national anti-doping organization (NADO). He also led the anti-doping program for the Vancouver Olympic and Paralympic Games in 2010. Jeremy joins us in this episode to talk about CCES, discuss how NADO’s have been dealing with the pandemic, and share his insights into what it takes to run anti-doping efforts during the Olympic and Paralympic Games.
59 – Developing New Activity-Based Bioassays to Screen for HIF Stabilizers – Liesl Janssens
Liesl Janssens is a PhD student in the Lab of Toxicology at Ghent University. Her virtual poster was a finalist in the PCC’s 2021 virtual poster session in the category of Pilot Studies. She is developing novel activity-based bioassays to screen for performance enhancing hypoxia-inducible factor (HIF) stabilizers. HIF stabilizers are small molecules that help to produce more blood cells by stimulating endogenous erythropoietin production. She shares more about this project and her work in this episode.